+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biospecific Antibody Market Analysis & Forecast to 2023-2033: Market By Drug Type; By Indication; By Distribution Channel; and by Region

  • PDF Icon

    Report

  • 145 Pages
  • July 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5848829
The global biospecific antibody market size was estimated to be USD 578.4 million in 2023 and is expected to reach at USD 1,316.0 million by 2033 with a CAGR of 7.76% during the forecast period 2023-2033. Rising rates of chronic diseases including cancer, autoimmune conditions, and infectious diseases, increasing need for targeted medicines, and developments in antibody engineering technologies are some of the key drivers driving market expansion.

Increasing prevalence of chronic diseases is expected to fuel the market growth. For instance, according to research issued in 2022 by the National Association of Chronic Disease Directors, over 60% of adult Americans have at least one chronic disease. Furthermore, 90% of the $3.8 trillion in yearly healthcare spending in the country is attributed to persons with chronic illnesses and mental health conditions, according to the Centres for Disease Control and Prevention. Bispecific antibodies offer a promising path for personalized therapy and tailored therapies in various disease areas to treat such diseases.

By drug type, the catumaxoab was the highest revenue-grossing segment in the global biospecific antibody market in 2022 due to the monoclonal antibodies' limitations in drug resistance and treatment failure. A monoclonal biospecific trifunctional antibody called catumaxoab is used to treat malignant ascites in rats and mice. It was created by Trion Pharma and Fresenius Biotech. Catumaxoab, marketed as Removab, is given to patients with EpCAM-positive cancer after being licensed and undergoing clinical trials in the United States. The blinatumomab market is expected to expand throughout the forecast period. Specific types of acute lymphocytic leukaemia that have not responded to treatment with other medications or have come back in adults and children are treated with blinatumomab.

By indication, the cancer segment accounted the highest share in the global biospecific antibody market in 2022 owing to prevalence of chronic diseases such oncological disorders, autoimmune disorders, and infectious diseases. These treatments present a potential strategy since they concurrently target several disease processes. For the treatment of gastric cancer, more than 15 bispecific antibodies are currently being developed. Akeso Biopharma announced in March 2023 that enrolment in a phase III trial for Cadonilimab, which is used in conjunction with chemotherapy as first-line treatment for advanced stomach or gastroesophageal junction cancer, had reached its conclusion. The inflammatory & autoimmune disorder is expected to have fastest CAGR during the forecast period due to rising cases of autoimmune disorder.

By distribution channel, the hospital pharmacy was the highest revenue-generating segment in 2022 due to improved guidelines, supportive health reimbursement systems, and active government initiatives for chronic diseases. The retail pharmacy market is predicted to expand throughout the forecast period, mostly because of manufacturers' increased focus on growing distribution networks, substantial increase in cancer incidence, and improved health infrastructure.

In 2022, the North American region accounted for the highest revenue in the biospecific antibody market during the forecast period. This is attributed to existence of several market players and the various developments undertaken by them. Other factors driving the regional market include increasing R&D spending, technological developments, and rising demand for bispecific antibodies. Additionally, the increasing interest and confidence of businesses to spend in R&D has increased with the regulatory authorities' approval of a number of bispecific antibodies. For instance, the first bispecific B-cell maturation antigen, teclistamab-cqyv (Tecvayli, Janssen Biotech, Inc.), received FDA approval in October 2022. Europe is predicted to experience the fastest CAGR during the forecast period. With a focus on precision medicine and a supportive regulatory framework, the region is well-positioned to take advantage of the special advantages of bispecific antibodies. Collaborations and partnerships between regional and international stakeholders also aid in the expansion of the region.

Segmentation: Biospecific Antibody Market Report 2022-2033

Biospecific Antibody Market Analysis & Forecast By Drug Type 2022-2033 (Revenue USD Mn)

  • Catumaxoab
  • Blinatumomab
  • Duligotumab

Biospecific Antibody Market Analysis & Forecast By Indication 2022-2033 (Revenue USD Mn)

  • Infectious
  • Cancer
  • CNS Disorders
  • Inflammatory and Autoimmune Disorders

Biospecific Antibody Market Analysis & Forecast By Distribution Channel 2022-2033 (Revenue USD Mn)

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Drug Stores

Biospecific Antibody Market Analysis & Forecast By Region 2022-2033 (Revenue USD Mn)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Method
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Biospecific Antibody Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Biospecific Antibody Market: Drug Type Estimates & Trend Analysis
7.1. Drug Type Segment Opportunity Analysis
7.2. Catumaxoab
7.2.1. Catumaxoab Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
7.3. Blinatumomab
7.3.1. Blinatumomab Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
7.4. Duligotumab
7.4.1. Duligotumab Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
8. Biospecific Antibody Market: Indication Estimates & Trend Analysis
8.1. Indication Segment Opportunity Analysis
8.2. Infectious
8.2.1. Infectious Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
8.3. Cancer
8.3.1. Cancer Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
8.4. CNS Disorders
8.4.1. CNS Disorders Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
8.5. Inflammatory and Autoimmune Disorders
8.5.1. Inflammatory and Autoimmune Disorders Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
9. Biospecific Antibody Market: Distribution Channel Estimates & Trend Analysis
9.1. Distribution Channel Segment Opportunity Analysis
9.2. Retail Pharmacies
9.2.1. Retail Pharmacies Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
9.3. Hospital Pharmacies
9.3.1. Hospital Pharmacies Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
9.4. Online Pharmacies
9.4.1. Online Pharmacies Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
9.5. Drug Stores
9.5.1. Drug Stores Market Analysis & Forecast, 2022-2033 (Revenue, USD Mn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Biospecific Antibody Market
11.1. North America Biospecific Antibody Market
11.1.1. North America Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
11.1.2. North America Biospecific Antibody Market Size and Forecast, By Country, 2022-2033 (Revenue USD Mn)
11.1.3. North America Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
11.1.4. North America Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
11.1.5. North America Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
11.2. U.S. Global Biospecific Antibody Market
11.2.1. U.S. Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
11.2.2. U.S. Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
11.2.3. U.S. Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
11.2.4. U.S. Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
11.3. Canada Global Biospecific Antibody Market
11.3.1. Canada Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
11.3.2. Canada Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
11.3.3. Canada Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
11.3.4. Canada Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
12. Europe Global Biospecific Antibody Market
12.1. Europe Global Biospecific Antibody Market
12.1.1. Europe Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
12.1.2. Europe Biospecific Antibody Market Size and Forecast, By Country, 2022-2033 (Revenue USD Mn)
12.1.3. Europe Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
12.1.4. Europe Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
12.1.5. Europe Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
12.2. Germany Global Biospecific Antibody Market
12.2.1. Germany Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
12.2.2. Germany Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
12.2.3. Germany Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
12.2.4. Germany Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
12.3. UK Global Biospecific Antibody Market
12.3.1. UK Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
12.3.2. UK Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
12.3.3. UK Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
12.3.4. UK Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
12.4. France Global Biospecific Antibody Market
12.4.1. France Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
12.4.2. France Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
12.4.3. France Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
12.4.4. France Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
12.5. Spain Global Biospecific Antibody Market
12.5.1. Spain Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
12.5.2. Spain Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
12.5.3. Spain Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
12.5.4. Spain Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
12.6. Italy Global Biospecific Antibody Market
12.6.1. Italy Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
12.6.2. Italy Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
12.6.3. Italy Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
12.6.4. Italy Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
12.7. Rest of Europe Global Biospecific Antibody Market
12.7.1. Rest of Europe Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
12.7.2. Rest of Europe Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
12.7.3. Rest of Europe Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
12.7.4. Rest of Europe Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
13. Asia Pacific Global Biospecific Antibody Market
13.1. Asia Pacific Global Biospecific Antibody Market
13.1.1. Asia Pacific Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
13.1.2. Asia Pacific Biospecific Antibody Market Size and Forecast, By Country, 2022-2033 (Revenue USD Mn)
13.1.3. Asia Pacific Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
13.1.4. Asia Pacific Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
13.1.5. Asia Pacific Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
13.2. Japan Global Biospecific Antibody Market
13.2.1. Japan Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
13.2.2. Japan Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
13.2.3. Japan Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
13.2.4. Japan Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
13.3. China Global Biospecific Antibody Market
13.3.1. China Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
13.3.2. China Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
13.3.3. China Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
13.3.4. China Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
13.4. India Global Biospecific Antibody Market
13.4.1. India Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
13.4.2. India Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
13.4.3. India Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
13.4.4. India Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
13.5. South Korea Global Biospecific Antibody Market
13.5.1. South Korea Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
13.5.2. South Korea Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
13.5.3. South Korea Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
13.5.4. South Korea Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
13.6. Australia Global Biospecific Antibody Market
13.6.1. Australia Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
13.6.2. Australia Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
13.6.3. Australia Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
13.6.4. Australia Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
13.7. Rest of Asia Pacific Global Biospecific Antibody Market
13.7.1. Rest of Asia Pacific Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
13.7.2. Rest of Asia Pacific Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
13.7.3. Rest of Asia Pacific Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
13.7.4. Rest of Asia Pacific Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
14. Latin America Global Biospecific Antibody Market
14.1. Latin America Global Biospecific Antibody Market
14.1.1. Latin America Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
14.1.2. Latin America Biospecific Antibody Market Size and Forecast, By Country, 2022-2033 (Revenue USD Mn)
14.1.3. Latin America Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
14.1.4. Latin America Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
14.1.5. Latin America Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
14.2. Brazil Global Biospecific Antibody Market
14.2.1. Brazil Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
14.2.2. Brazil Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
14.2.3. Brazil Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
14.2.4. Brazil Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
14.3. Mexico Global Biospecific Antibody Market
14.3.1. Mexico Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
14.3.2. Mexico Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
14.3.3. Mexico Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
14.3.4. Mexico Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
14.4. Argentina Global Biospecific Antibody Market
14.4.1. Argentina Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
14.4.2. Argentina Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
14.4.3. Argentina Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
14.4.4. Argentina Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
14.5. Rest of Latin America Global Biospecific Antibody Market
14.5.1. Rest of Latin America Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
14.5.2. Rest of Latin America Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
14.5.3. Rest of Latin America Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
14.5.4. Rest of Latin America Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
15. MEA Global Biospecific Antibody Market
15.1. MEA Global Biospecific Antibody Market
15.1.1. MEA Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
15.1.2. MEA Biospecific Antibody Market Size and Forecast, By Country, 2022-2033 (Revenue USD Mn)
15.1.3. MEA Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
15.1.4. MEA Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
15.1.5. MEA Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
15.2. GCC Global Biospecific Antibody Market
15.2.1. GCC Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
15.2.2. GCC Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
15.2.3. GCC Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
15.2.4. GCC Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
15.3. South Africa Global Biospecific Antibody Market
15.3.1. South Africa Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
15.3.2. South Africa Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
15.3.3. South Africa Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
15.3.4. South Africa Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
15.4. Rest of MEA Global Biospecific Antibody Market
15.4.1. Rest of MEA Biospecific Antibody Market Size and Forecast, 2022-2033 (Revenue USD Mn)
15.4.2. Rest of MEA Biospecific Antibody Market Size and Forecast, By Drug Type, 2022-2033 (Revenue USD Mn)
15.4.3. Rest of MEA Biospecific Antibody Market Size and Forecast, By Indication, 2022-2033 (Revenue USD Mn)
15.4.4. Rest of MEA Biospecific Antibody Market Size and Forecast, By Distribution Channel, 2022-2033 (Revenue USD Mn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2022
16.2. Major Recent Developments
17. Company Profiles
17.1. Amgen
17.2. Genentech
17.3. Janssen
17.4. Immunocore
17.5. Taisho Pharmaceutical
17.6. Bayer AG
17.7. Pfizer Inc.
17.8. Merck Amgen
17.9. OncoMed Pharmaceuticals
17.10. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • Amgen
  • Genentech
  • Janssen
  • Immunocore
  • Taisho Pharmaceutical
  • Bayer AG
  • Pfizer Inc.
  • Merck Amgen
  • OncoMed Pharmaceuticals

Table Information